USFDA panel backs restricted use of AstraZeneca Prostrate cancer drug Ruchika Sharma29 April 2023 12:30 PM ISTLynparza belongs to a class of drugs called PARP inhibitors, which include Clovis Oncology's Rubraca and GSK Plc's Zejula.
Merck-Moderna vaccine helps keep patients free from skin cancer Roshni Dhar17 April 2023 6:00 PM ISTAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by...
Health Bulletin 17/April/2023 Roshni Dhar17 April 2023 4:29 PM ISTHere are the top health stories for the day:NEET UG 2023: NTA revises eligibility criteria for Indian candidates abroadThe NEET exam conducting body...
Merck to acquire Prometheus Biosciences for USD 11 billion Ruchika Sharma17 April 2023 12:30 PM ISTRahway: Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. have announced that the companies have entered into...
USFDA pauses initiation of new patients on multiple sclerosis evobrutinib drug: Merck Ruchika Sharma15 April 2023 11:19 AM ISTThe company must now place on hold the initiation of new evobrutinib patients and halt studies involving patients who have been taking the drug for...
USFDA accepts application for Merck KEYTRUDA plus Chemotherapy as first line treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Ruchika Sharma14 April 2023 11:00 AM ISTKEYTRUDA is an anti-programmed death receptor-1 therapy that works by increasing the ability of the body's immune system to help detect and fight...
Merck, Moderna get PRIME scheme designation from EMA for personalized mRNA cancer vaccine, KEYTRUDA combo for adjuvant treatment of High-risk Melanoma Ruchika Sharma9 April 2023 2:30 PM ISTMelanoma, the most serious form of skin cancer, is characterized by the uncontrolled growth of pigment-producing cells.
Setback: Merck, Eisai to stop late-stage study of Keytruda plus Lenvima for metastatic melanoma Ruchika Sharma8 April 2023 2:01 PM ISTThey also said another late-stage trial for Keytruda and Lenvima did not meet its main goal of overall survival for treating a type of colorectal or...
Merck gets USFDA nod for Keytruda in combination with Padcev to treat Advanced or Metastatic Urothelial Cancer Ruchika Sharma5 April 2023 1:16 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
Bayer defeats Merck in lawsuit over talc liabilities Ruchika Sharma4 April 2023 3:00 PM IST"Bayer will continue to defend itself against any further efforts by Merck to avoid or improperly transfer its liabilities to Bayer," the company said...
Merck Keytruda gets full USFDA approval for advanced MSI-H or dMMR solid tumors Ruchika Sharma1 April 2023 12:15 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
KEYTRUDA plus chemotherapy improves overall survival versus chemotherapy alone to treat advanced malignant pleural mesothelioma: Merck Ruchika Sharma13 March 2023 2:27 PM ISTMalignant mesothelioma is a type of cancer that starts in the linings of certain parts of the body, including the chest, abdomen, heart and testicles.
